GenEmbryomics Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
IPO
- (Cancelled)
- Latest Deal Amount
-
$10.3M
- Investors
-
4
GenEmbryomics General Information
Description
GenEmbryomics Ltd is a genomics-based company empowering families to have healthy children by providing in-vitro fertilization (IVF) patients and providers insights into an embryo's genetic disease. Its test Panacea-GenomeScreen provides preimplantation genetic testing via whole genome sequencing (PGT-WGS) of individuals, couples and IVF embryos..
Contact Information
Website
www.genembryomics.comCorporate Office
- 580 California Street
- 12th Floor 9971
- San Francisco, CA 94104
- United States
Corporate Office
- 580 California Street
- 12th Floor 9971
- San Francisco, CA 94104
- United States
GenEmbryomics Timeline
GenEmbryomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. IPO | 23-Apr-2025 | $10.3M | Cancelled | Generating Revenue | ||
| 3. Accelerator/Incubator | 25-Jul-2024 | Completed | Generating Revenue | |||
| 2. Debt - General | 01-Aug-2023 | Completed | Generating Revenue | |||
| 1. Early Stage VC | 14-Jun-2022 | Completed | Generating Revenue |
GenEmbryomics Patents
GenEmbryomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020369151-A1 | Method for screening ivf embryos | Pending | 22-Oct-2019 | ||
| EP-4048810-A1 | Method for screening ivf embryos | Pending | 22-Oct-2019 | ||
| EP-4048810-A4 | Method for screening ivf embryos | Pending | 22-Oct-2019 | ||
| US-20220392570-A1 | Method for screening ivf embryos | Pending | 22-Oct-2019 | ||
| WO-2021077163-A1 | Method for screening ivf embryos | Inactive | 22-Oct-2019 | G16B20/20 |
GenEmbryomics Signals
GenEmbryomics Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Medtech Actuator | Accelerator/Incubator | Minority | ||
| Artesian | Venture Capital | Minority | ||
| Boab | Venture Capital | Minority | ||
| Homu Health Ventures | Venture Capital | Minority |
GenEmbryomics FAQs
-
When was GenEmbryomics founded?
GenEmbryomics was founded in 2019.
-
Where is GenEmbryomics headquartered?
GenEmbryomics is headquartered in San Francisco, CA.
-
What is the size of GenEmbryomics?
GenEmbryomics has 5 total employees.
-
What industry is GenEmbryomics in?
GenEmbryomics’s primary industry is Biotechnology.
-
Is GenEmbryomics a private or public company?
GenEmbryomics is a Private company.
-
What is the current valuation of GenEmbryomics?
The current valuation of GenEmbryomics is .
-
What is GenEmbryomics’s current revenue?
The current revenue for GenEmbryomics is .
-
How much funding has GenEmbryomics raised over time?
GenEmbryomics has raised $860K.
-
Who are GenEmbryomics’s investors?
Medtech Actuator, Artesian, Boab, and Homu Health Ventures have invested in GenEmbryomics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process